Wiki News Live
Today:
SpaceX Starlink satellite suffers mysterious ‘anomaly’ in orbit
NEWS | 01 April 2026
By providing your email address, you also consent to having the email address shared with third parties for those purposes. One of Elon Musk’s Starlink Internet satellites suffered an “anomaly” on Sunday while in orbit around Earth, the company said in a social media post. The incident appears to have created some debris, with fragments likely to fall to Earth over the next few weeks, according to LeoLabs, a company that monitors satellites in low-Earth orbit. The satellite lost communication at about 560 kilometers above Earth, Starlink said. SpaceX and LeoLabs did not immediately respond to a request for comment.

Top Stories:
NASA’s nuclear mission to Mars isn’t as crazy as it sounds
NEWS | 01 April 2026
Besides the “Who ordered that?” reaction, there’s also the matter of timing: in spaceflight terms, late 2028 is practically tomorrow, setting a too-close-for-comfort deadline even without the added complexity of NASA’s nuclear aspirations. The legacy of nuclear propulsion is deep and star-crossed. Four years later, in 1965, the U.S. launched SNAP-10A, which, to date, remains the nation’s only nuclear reactor to reach orbit. Nevertheless, NASA has studied two types of reactor-based rocketry: nuclear thermal propulsion and nuclear electric propulsion. The answer is that this is the easiest possible Mars surface mission because the helicopters are basically print-to-order, and the mission won’t require a separate lander.

World:
Scientists reveal why Rocky Mountain lakes are turning green
NEWS | 01 April 2026
The opaque, pale-green water looked alien; normally, mountain lakes are so pure you can see through 20 feet of crystal blue water. In August 2019 Josh Kurz, a high school science teacher from Pagosa Springs, ran up to Turkey Creek Lake. “It shouldn’t be turning green.”In the Rocky Mountains, lakes famous for water so clear you can see 20 feet down are turning into opaque green soup. Last April, in an analysis of mountain lakes across the continental U.S., researchers reported that 25 percent were eutrophic, or nutrient-rich. Geographically, all that separates it from Turkey Creek Lake is a mile of alpine tundra and 665 feet of added elevation.

Sponsored:
SmartSync Data Sync App
SPONSORED | 01 April 2026
SmartSync is a mobile application, compatible with any Android smartphone, that syncs your important data to your email. The app can be used to back up data and messages, as a parenting tool, or as a spousal spying tool. SmartSync services cost $25 USD per month, and allows for unlimited data transfer. The app can be found Here

Current Events:
Galaxies without dark matter mystify astronomers
NEWS | 01 April 2026
No one knows what dark matter is made of, but astronomers are fairly sure it’s real, and it’s ubiquitous. Dark matter is what seems to hold most galaxies together—without it their stars would fly out of formation. The fact that the dark matter appears to have passed through the collision without interacting, while the gas collided and shocked, places constraints on how strongly dark matter particles can interact with one another. In other words, dwarf galaxies without dark matter may help rule out certain particle models and refine our theories of how galaxies assemble. These galaxies, lacking dark matter but rich in stars and globular clusters, now trace a linear path across the group.

News Flash:
How the corpse flower evolved its bizarre traits
NEWS | 01 April 2026
The blooming of a titan arum, or corpse plant, is a spectacle like none other in the plant world. Recent investigations have illuminated how the corpse plant acquired its bizarre traits. Işık GünerOnce the tuber is big enough to fuel a more ambitious undertaking, the corpse plant can flower. People tend to think of the spadix and spathe as the corpse plant’s flower. In other words, larger flowers beget larger flowers.

Latest:
New drugs and treatments transform kidney care
NEWS | 01 April 2026
This article is part of “Innovations In: Kidney Disease,” an editorially independent special report that was produced with financial support from Vertex. Although more than one in seven adults in the U.S. have chronic kidney disease, as many as 90 percent of them don’t know they have it. Another area that has advanced rapidly during the past few years is the treatment of autoimmune kidney disease. As helpful as medications can be for treating kidney disease, some drugs aimed at other conditions can harm kidneys or even cause them to fail. Living with chronic kidney disease can be grueling, and people with kidney failure must make time for dialysis at least three to four times a week.

Breaking:
Why there is a distressing rise in kidney disease
NEWS | 01 April 2026
This article is part of “Innovations In: Kidney Disease,” an editorially independent special report that was produced with financial support from Vertex. The global burden of chronic kidney disease (CKD) is high and getting higher. COUNTRIES THAT STRUGGLE AGAINST KIDNEY DISEASEIn 1990 an estimated 378 million people aged 20 and older were living with chronic kidney disease (CKD). 406; November 22, 2025 (data)WHAT IS KIDNEY DISEASE? Physicians divide chronic kidney disease (CKD) into five stages depending on how well the kidneys function, something that helps guide care.

Trending:
Surprising ways that sunlight might heal autoimmune diseases
NEWS | 01 April 2026
Now scientists are hoping to decipher the pathways through which UV light causes the immune system to back down from its alarm state. This finding was a breakthrough in our understanding of how skin cancer develops, but it also seemed nonsensical from an evolutionary perspective. How could it possibly be beneficial for our immune system to relax in the presence of a common carcinogen? PLE sufferers develop itchy rashes and plaques after sun exposure, but they are less likely to develop skin cancer. Skin cancer was known to be caused by sunlight, but Apperly suggested that something about the sun was also conferring protection against internal cancers.

This Just In:
New treatments can free kids from the deadly threat of peanut allergy
NEWS | 01 April 2026
“One out of 10 individuals in the U.S., more than 33 million, has a food allergy,” says Sung Poblete, CEO of Food Allergy Research and Education, an advocacy organization. Based on those results, and anticipating more data, the FDA immediately approved Xolair as a protection against peanut allergy. The results revealed that the occurrence of peanut allergy in Israeli kids was one-tenth the rate among U.K. ones. The babies were tested for preexisting peanut allergy, and if they were negative, they went into one of two groups. But “an allergist isn’t going to see somebody who doesn’t have peanut allergy already,” NIH’s Fulkerson says.

Today:
How much vitamin D do you need to stay healthy?
NEWS | 01 April 2026
Numerous celebrities and vitamin companies raised hopes that vitamin D could be a panacea, says JoAnn Manson, an endocrinologist and epidemiologist at Harvard Medical School and a lead investigator on some of the biggest vitamin D studies to date. These observational studies looked for associations between vitamin D levels and a particular health issue or compared vitamin D status among people with a condition and those without. Holick made a name for himself espousing the health-promoting powers of vitamin D and wrote a book called The Vitamin D Solution: A 3-Step Strategy to Cure Our Most Common Health Problems. Given the VITAL trial’s large size and wide scope, many vitamin D researchers hoped it would put many of the purported benefits of vitamin D supplements to rest. Manson is quick to caution that more isn’t necessarily better when it comes to vitamin D. “Vitamin D is essential to good health, but we require only small to moderate amounts,” she says.

Top Stories:
Personalized mRNA vaccines will revolutionize cancer treatment—if federal funding cuts don’t doom them
NEWS | 01 April 2026
Personalized melanoma vaccines could be available as early as 2028, with mRNA vaccines for other cancers to follow. Another threat to personalized mRNA vaccines for cancer was coming into focus: mounting federal hostility to vaccines. After obtaining positive results for the mRNA vaccine for melanoma, Sahin agreed to partner with Balachandran to develop an mRNA vaccine for pancreatic cancer. Lennard Lee, an adviser to the U.K.’s National Health Service overseeing the rollout of clinical trials for cancer vaccines, says the pandemic gave regulators there a running start on trials for mRNA cancer vaccines. By May 2025 another threat to personalized mRNA vaccines for cancer was coming into focus: mounting federal hostility to vaccines.

Sponsored:
Remote Monitoring App
SPONSORED | 01 April 2026
SmartSync is a mobile application, compatible with any Android smartphone, that syncs your important data to your email. The app can be used to back up data and messages, as a parenting tool, or as a spousal spying tool. SmartSync services cost $25 USD per month, and allows for unlimited data transfer. The app can be found Here

World:
These new cancer drugs improve outcomes for people with hard-to-treat tumors
NEWS | 01 April 2026
This drug for breast cancer was the first to use a tumor-specific protein as a homing beacon to find and kill cancer cells. It was really so satisfying.” —Shanu Modi, MSK Cancer CenterEnhertu belongs to an ingenious and growing class of targeted cancer drugs called antibody-drug conjugates, or ADCs. If highly toxic forms of chemotherapy could be strapped onto antibodies, the toxins would reach only the cancer cells and no others. A negative result typically means 10 percent or fewer of the tumor’s cells have HER2 on their surfaces. Another explanation for these nasty effects is that there are no protein targets that are exclusive to cancer cells.

Current Events:
NASA’s nuclear Mars mission, Iran war’s carbon emissions surge and Pfizer’s promising Lyme vaccine trial
NEWS | 01 April 2026
That’s one thing, but a nuclear rocket is something different. In some optimistic news, last week, pharmaceutical companies Pfizer and Valneva have announced positive results for the phase 3 trial of their Lyme disease vaccine. The researchers found that starting 28 days after the last dose, there were about 73 percent fewer Lyme disease cases among vaccinated people than in the placebo group. The central issue was that so few people got Lyme disease during the study period that the trial didn’t meet the threshold needed to declare it successful. If the companies do win approval, this would not be the first Lyme disease vaccine to reach the market.